Ibere Pharmaceuticals (NYSE:IBER.U) announced that it has entered into a purchase agreement for a private placement of up to 4,835,000 warrants at a purchase price of $1 per warrant for gross proceeds of $4,835,000 on February 25, 2021. The number of warrant being issued is depending on the extent to which the over-allotment option is exercised in full. Each warrant entitles the holder to purchase one ordinary share at an exercise price of $11.5 per share. The closing of the transaction shall take place simultaneously with the closing of the public offering. The securities will be issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.